Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vivo Bio Tech has submitted a compliance report regarding SEBI's special window for re-lodgement of physical share transfer requests, introduced via circular dated January 30, 2026. The filing covers the period ended March 2026 and reports NIL (zero) requests received from shareholders for re-lodgement of physical share transfers. The Company's Registrar and Transfer Agent, Aarthi Consultants Private Limited, has confirmed zero activity during this period. Both the Company Secretary and Compliance Officer have signed off on this NIL status report.
This is a routine regulatory compliance filing with no direct impact on shareholders. Zero requests indicate that no shareholders sought to re-lodge physical share transfers under the SEBI special provision, which may suggest most shares are already in demat form.